chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Coronary artery disease, Dialysis, Diastolic dysfunction, Dyspnoea, Echocardiogram
Clinical narrative: Patient is a 59 y.o. female with past medical history of hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, chronic diastolic CHF, chronic hypoxemic respiratory failure on 3 L of oxygen through nasal cannula, end-stage renal disease on regular hemodialysis sessions, presented with viral syndrome 4 days duration   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Presumed COPD Presumed obstructive sleep apnea Date of onset of symptoms: 12/14/2022 Symptoms present on admission: Fever chills, rhinorrhea, sore throat, productive cough of yellow sputum, shortness of breath generalized weakness and fatigue Date of covid positive test: 12/18/2022 Vaccination status: vaccinated Imaging: Chest x-ray no infiltrate Oxygen requirements on admission: 3 L NC of oxygen through nasal cannula Current oxygen requirements: 3L Medical therapy: steroids, rocephin, and zithromax, remdesivir.  Antibiotics were discontinued per ID Consultants following: Infectious disease consult Anticipated special isolation end date: 12/28/2022 Continue incentive spirometry and bronchodilators Outpatient pulmonary function test and sleep study   She finished 5 days of remdesivir 10 days of dexamethasone. Now on baseline 3 L nasal cannula during day.  CPAP at nighttime. Lung exam improved. Okay to be discharged home today.   Acute on chronic diastolic congestive heart failure History of coronary artery disease Echocardiogram 10/7/2022 showed normal EF 70%.  Grade 2 diastolic dysfunction.  Pulmonary hypertension RVSP 48 mmHg. Reduced average global longitudinal strain of -12.9%.  Pattern suggestive of cardiac amyloid. Left heart catheterization on November 2022 showed severe two-vessel coronary artery disease with successful percutaneous coronary intervention RCA ISR with POBA. Ultrafiltration with dialysis.  Currently close to euvolemic.  History of hypertension Discharge regimen with Imdur 30 mg daily, Coreg 25 mg twice daily, hydralazine 100 g 3 times daily and Clonidine patch weekly. Initially nifedipine 60 mg twice daily was stopped on admission, resumed at low-dose 30 mg daily. Blood pressure stable over last 24 to 48 hours before discharge.   Insulin-dependent diabetes mellitus Diabetic neuropathy Continue home dose Lantus 10 units nightly and insulin sliding scale. Hemoglobin A1c 6.2 Continue home gabapentin twice daily  End-stage renal disease on regular hemodialysis sessions Anemia of chronic disease Metabolic acidosis Nephrology consulted to resume HD and UF   Hyperlipidemia Atorvastatin 80 mg daily   Moderate protein calorie malnutrition Nutrition consult
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction, Ejection fraction normal, Fatigue, Glycosylated haemoglobin
Clinical narrative: Patient is a 59 y.o. female with past medical history of hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, chronic diastolic CHF, chronic hypoxemic respiratory failure on 3 L of oxygen through nasal cannula, end-stage renal disease on regular hemodialysis sessions, presented with viral syndrome 4 days duration   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Presumed COPD Presumed obstructive sleep apnea Date of onset of symptoms: 12/14/2022 Symptoms present on admission: Fever chills, rhinorrhea, sore throat, productive cough of yellow sputum, shortness of breath generalized weakness and fatigue Date of covid positive test: 12/18/2022 Vaccination status: vaccinated Imaging: Chest x-ray no infiltrate Oxygen requirements on admission: 3 L NC of oxygen through nasal cannula Current oxygen requirements: 3L Medical therapy: steroids, rocephin, and zithromax, remdesivir.  Antibiotics were discontinued per ID Consultants following: Infectious disease consult Anticipated special isolation end date: 12/28/2022 Continue incentive spirometry and bronchodilators Outpatient pulmonary function test and sleep study   She finished 5 days of remdesivir 10 days of dexamethasone. Now on baseline 3 L nasal cannula during day.  CPAP at nighttime. Lung exam improved. Okay to be discharged home today.   Acute on chronic diastolic congestive heart failure History of coronary artery disease Echocardiogram 10/7/2022 showed normal EF 70%.  Grade 2 diastolic dysfunction.  Pulmonary hypertension RVSP 48 mmHg. Reduced average global longitudinal strain of -12.9%.  Pattern suggestive of cardiac amyloid. Left heart catheterization on November 2022 showed severe two-vessel coronary artery disease with successful percutaneous coronary intervention RCA ISR with POBA. Ultrafiltration with dialysis.  Currently close to euvolemic.  History of hypertension Discharge regimen with Imdur 30 mg daily, Coreg 25 mg twice daily, hydralazine 100 g 3 times daily and Clonidine patch weekly. Initially nifedipine 60 mg twice daily was stopped on admission, resumed at low-dose 30 mg daily. Blood pressure stable over last 24 to 48 hours before discharge.   Insulin-dependent diabetes mellitus Diabetic neuropathy Continue home dose Lantus 10 units nightly and insulin sliding scale. Hemoglobin A1c 6.2 Continue home gabapentin twice daily  End-stage renal disease on regular hemodialysis sessions Anemia of chronic disease Metabolic acidosis Nephrology consulted to resume HD and UF   Hyperlipidemia Atorvastatin 80 mg daily   Moderate protein calorie malnutrition Nutrition consult
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Percutaneous coronary intervention, Positive airway pressure therapy, Productive cough, Pulmonary function test, Pulmonary function test abnormal
Clinical narrative: Patient is a 59 y.o. female with past medical history of hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, chronic diastolic CHF, chronic hypoxemic respiratory failure on 3 L of oxygen through nasal cannula, end-stage renal disease on regular hemodialysis sessions, presented with viral syndrome 4 days duration   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Presumed COPD Presumed obstructive sleep apnea Date of onset of symptoms: 12/14/2022 Symptoms present on admission: Fever chills, rhinorrhea, sore throat, productive cough of yellow sputum, shortness of breath generalized weakness and fatigue Date of covid positive test: 12/18/2022 Vaccination status: vaccinated Imaging: Chest x-ray no infiltrate Oxygen requirements on admission: 3 L NC of oxygen through nasal cannula Current oxygen requirements: 3L Medical therapy: steroids, rocephin, and zithromax, remdesivir.  Antibiotics were discontinued per ID Consultants following: Infectious disease consult Anticipated special isolation end date: 12/28/2022 Continue incentive spirometry and bronchodilators Outpatient pulmonary function test and sleep study   She finished 5 days of remdesivir 10 days of dexamethasone. Now on baseline 3 L nasal cannula during day.  CPAP at nighttime. Lung exam improved. Okay to be discharged home today.   Acute on chronic diastolic congestive heart failure History of coronary artery disease Echocardiogram 10/7/2022 showed normal EF 70%.  Grade 2 diastolic dysfunction.  Pulmonary hypertension RVSP 48 mmHg. Reduced average global longitudinal strain of -12.9%.  Pattern suggestive of cardiac amyloid. Left heart catheterization on November 2022 showed severe two-vessel coronary artery disease with successful percutaneous coronary intervention RCA ISR with POBA. Ultrafiltration with dialysis.  Currently close to euvolemic.  History of hypertension Discharge regimen with Imdur 30 mg daily, Coreg 25 mg twice daily, hydralazine 100 g 3 times daily and Clonidine patch weekly. Initially nifedipine 60 mg twice daily was stopped on admission, resumed at low-dose 30 mg daily. Blood pressure stable over last 24 to 48 hours before discharge.   Insulin-dependent diabetes mellitus Diabetic neuropathy Continue home dose Lantus 10 units nightly and insulin sliding scale. Hemoglobin A1c 6.2 Continue home gabapentin twice daily  End-stage renal disease on regular hemodialysis sessions Anemia of chronic disease Metabolic acidosis Nephrology consulted to resume HD and UF   Hyperlipidemia Atorvastatin 80 mg daily   Moderate protein calorie malnutrition Nutrition consult
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary hypertension, Pyrexia, Respiratory failure, Rhinorrhoea, SARS-CoV-2 test
Clinical narrative: Patient is a 59 y.o. female with past medical history of hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, chronic diastolic CHF, chronic hypoxemic respiratory failure on 3 L of oxygen through nasal cannula, end-stage renal disease on regular hemodialysis sessions, presented with viral syndrome 4 days duration   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Presumed COPD Presumed obstructive sleep apnea Date of onset of symptoms: 12/14/2022 Symptoms present on admission: Fever chills, rhinorrhea, sore throat, productive cough of yellow sputum, shortness of breath generalized weakness and fatigue Date of covid positive test: 12/18/2022 Vaccination status: vaccinated Imaging: Chest x-ray no infiltrate Oxygen requirements on admission: 3 L NC of oxygen through nasal cannula Current oxygen requirements: 3L Medical therapy: steroids, rocephin, and zithromax, remdesivir.  Antibiotics were discontinued per ID Consultants following: Infectious disease consult Anticipated special isolation end date: 12/28/2022 Continue incentive spirometry and bronchodilators Outpatient pulmonary function test and sleep study   She finished 5 days of remdesivir 10 days of dexamethasone. Now on baseline 3 L nasal cannula during day.  CPAP at nighttime. Lung exam improved. Okay to be discharged home today.   Acute on chronic diastolic congestive heart failure History of coronary artery disease Echocardiogram 10/7/2022 showed normal EF 70%.  Grade 2 diastolic dysfunction.  Pulmonary hypertension RVSP 48 mmHg. Reduced average global longitudinal strain of -12.9%.  Pattern suggestive of cardiac amyloid. Left heart catheterization on November 2022 showed severe two-vessel coronary artery disease with successful percutaneous coronary intervention RCA ISR with POBA. Ultrafiltration with dialysis.  Currently close to euvolemic.  History of hypertension Discharge regimen with Imdur 30 mg daily, Coreg 25 mg twice daily, hydralazine 100 g 3 times daily and Clonidine patch weekly. Initially nifedipine 60 mg twice daily was stopped on admission, resumed at low-dose 30 mg daily. Blood pressure stable over last 24 to 48 hours before discharge.   Insulin-dependent diabetes mellitus Diabetic neuropathy Continue home dose Lantus 10 units nightly and insulin sliding scale. Hemoglobin A1c 6.2 Continue home gabapentin twice daily  End-stage renal disease on regular hemodialysis sessions Anemia of chronic disease Metabolic acidosis Nephrology consulted to resume HD and UF   Hyperlipidemia Atorvastatin 80 mg daily   Moderate protein calorie malnutrition Nutrition consult
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sleep study, Sputum discoloured, Viral infection
Clinical narrative: Patient is a 59 y.o. female with past medical history of hypertension, hyperlipidemia, diabetes mellitus, coronary artery disease, chronic diastolic CHF, chronic hypoxemic respiratory failure on 3 L of oxygen through nasal cannula, end-stage renal disease on regular hemodialysis sessions, presented with viral syndrome 4 days duration   Covid-19 Virus Infection Chronic hypoxemic respiratory failure Presumed COPD Presumed obstructive sleep apnea Date of onset of symptoms: 12/14/2022 Symptoms present on admission: Fever chills, rhinorrhea, sore throat, productive cough of yellow sputum, shortness of breath generalized weakness and fatigue Date of covid positive test: 12/18/2022 Vaccination status: vaccinated Imaging: Chest x-ray no infiltrate Oxygen requirements on admission: 3 L NC of oxygen through nasal cannula Current oxygen requirements: 3L Medical therapy: steroids, rocephin, and zithromax, remdesivir.  Antibiotics were discontinued per ID Consultants following: Infectious disease consult Anticipated special isolation end date: 12/28/2022 Continue incentive spirometry and bronchodilators Outpatient pulmonary function test and sleep study   She finished 5 days of remdesivir 10 days of dexamethasone. Now on baseline 3 L nasal cannula during day.  CPAP at nighttime. Lung exam improved. Okay to be discharged home today.   Acute on chronic diastolic congestive heart failure History of coronary artery disease Echocardiogram 10/7/2022 showed normal EF 70%.  Grade 2 diastolic dysfunction.  Pulmonary hypertension RVSP 48 mmHg. Reduced average global longitudinal strain of -12.9%.  Pattern suggestive of cardiac amyloid. Left heart catheterization on November 2022 showed severe two-vessel coronary artery disease with successful percutaneous coronary intervention RCA ISR with POBA. Ultrafiltration with dialysis.  Currently close to euvolemic.  History of hypertension Discharge regimen with Imdur 30 mg daily, Coreg 25 mg twice daily, hydralazine 100 g 3 times daily and Clonidine patch weekly. Initially nifedipine 60 mg twice daily was stopped on admission, resumed at low-dose 30 mg daily. Blood pressure stable over last 24 to 48 hours before discharge.   Insulin-dependent diabetes mellitus Diabetic neuropathy Continue home dose Lantus 10 units nightly and insulin sliding scale. Hemoglobin A1c 6.2 Continue home gabapentin twice daily  End-stage renal disease on regular hemodialysis sessions Anemia of chronic disease Metabolic acidosis Nephrology consulted to resume HD and UF   Hyperlipidemia Atorvastatin 80 mg daily   Moderate protein calorie malnutrition Nutrition consult
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was given the Pfizer monovalent shot as a booster instead of a Pfizer Bivalent booster shot
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Diarrhoea, Stool analysis normal, Weight decreased
Clinical narrative: I've had diarrhea for 10 weeks since receiving my latest booster; I've lost 13lbs in the last 10 days. I have an appointment with my physician to find a diagnosis and proper resolution. They conducted stool tests which all came back negative for any pathological infections or parasites.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Cough, Fatigue, Influenza virus test negative, SARS-CoV-2 test negative, Sleep disorder
Clinical narrative: I started with a cough that got severe and couldn't sleep. I went to the doctor and was prescribed a medication which I took. The cough is finally slowly going away. I have felt at times for a long time was exhausted after COVID-19 last year. I also have COPD.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anal incontinence, Computerised tomogram, Electrocardiogram, Fall, Laboratory test
Clinical narrative: Patient had syncopial episode at home, leading to fall. Patient became completely unresponsive and voided bowels during episode. Brought to ER.
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Patient had syncopial episode at home, leading to fall. Patient became completely unresponsive and voided bowels during episode. Brought to ER.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Fatigue, Nasal congestion, Oropharyngeal pain
Clinical narrative: After the vaccine, I woke up with a little soreness on my arm. My symptoms started on 12/28 I had running nose, fever, sore throat, and then that night chills, body ache, next day extreme fatigue. I had a COVID-19 test on Dec 30th the in the evening and it was positive. I called my doctor on 12/31 and prescribed PAXLOVID. My symptoms lasted for three days, but fatigue still continues, and also nose congestion. I started taking PAXLOVID on December 31st, today is my last day.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pain in extremity, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: After the vaccine, I woke up with a little soreness on my arm. My symptoms started on 12/28 I had running nose, fever, sore throat, and then that night chills, body ache, next day extreme fatigue. I had a COVID-19 test on Dec 30th the in the evening and it was positive. I called my doctor on 12/31 and prescribed PAXLOVID. My symptoms lasted for three days, but fatigue still continues, and also nose congestion. I started taking PAXLOVID on December 31st, today is my last day.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Cough, Electrocardiogram, Fatigue, Full blood count normal
Clinical narrative: I had a terrible sore throat, laryngitis; cough; head and ear congestion; fatigue; fever and body aches. This lasted for 6 weeks. On 09/08/2021 I noticed that my BP was 188. I went to urgent care and they referred me to the ER. I have never had any Hypertension issues in my life, I attribute this to my 3rd dose.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Laryngitis, Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I had a terrible sore throat, laryngitis; cough; head and ear congestion; fatigue; fever and body aches. This lasted for 6 weeks. On 09/08/2021 I noticed that my BP was 188. I went to urgent care and they referred me to the ER. I have never had any Hypertension issues in my life, I attribute this to my 3rd dose.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Blood sodium decreased, COVID-19, Chest X-ray abnormal, Computerised tomogram head normal, Confusional state
Clinical narrative: Patient is a 79 y.o. female admitted to the hospital on 12/25/2022 for with fever, intermittent confusion, cough, and positive COVID test. Symptoms improved with fluids and supportive therapy. Briefly placed on 2L O2 however likely did not need this. Received 1 dose of dexamethasone. Discharge home with no changes to meds. Considered paxlovid however avoided due to interaction with home eliquis.   Discharge Diagnosis and Hospital Course   Comments/Problems to be Addressed After Discharge - Follow up with PCP in 1 week for hospital follow up. Isolate for 5 days post symptoms onset and wear a mask around people for 10 days post symptom onset. Advised patient to monitor O2 levels at home.    COVID-19 - Symptom onset 12/21 with cough, sore throat, congestion, fever, and confusion when febrile. Positive test 12/24. Vaccinated and boosted. Received 4 total shots with last in April 2022.  - CXR on admit w/ few areas of interstitial changes but overall unremarkable. - Briefly on 1-2L. Received 1 dose dexamethasone.  - Does not qualify for remdesivir. Considered paxlovid on discharge however concern for significant interaction with eliquis.  - Weaned off O2 and no need for home O2. Follow up with PCP in 1 week.    Acute encephalopathy, resolved - In setting of parkinson's disease and likely metabolic with hyponatremia contributing. Reported periods of confusion when she was febrile PTA, would improve as fever resolved. - CT head on admission unremarkable. - Alert and oriented on exam this morning without focal neurological deficits.   Hyponatremia - Likely in setting of PO intake. Sodium 126 on admission. Was started on LR infusion for about ~1.5 L in. - Urine sodium of 46. Osmolality 275. - Improved to 130 s/p fluids.    Permanent Atrial Fibrillation - With single-chamber pacemaker.  Follows with Dr.  - Continue home Eliquis and Coreg.  Parkinson's disease - Follows with Dr. in movement clinic and on carbidopa/levodopa and midodrine for orthostasis. - Continue home dosing of carbidopa/levodopa. Patient has follow up scheduled with neurology.   Hypertension with history of orthostatic hypotension - Continue home carvedilol 12.5 mg daily and midodrine with carbidopa/levodopa orthostasis. - Can tolerate some supine hypertension if needed.   Hypothyroidism - Continue home Armour Thyroid 60 mg daily.   Depression and anxiety - Continue home paroxetine
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Encephalopathy, Hyponatraemia, Oropharyngeal pain, Pyrexia
Clinical narrative: Patient is a 79 y.o. female admitted to the hospital on 12/25/2022 for with fever, intermittent confusion, cough, and positive COVID test. Symptoms improved with fluids and supportive therapy. Briefly placed on 2L O2 however likely did not need this. Received 1 dose of dexamethasone. Discharge home with no changes to meds. Considered paxlovid however avoided due to interaction with home eliquis.   Discharge Diagnosis and Hospital Course   Comments/Problems to be Addressed After Discharge - Follow up with PCP in 1 week for hospital follow up. Isolate for 5 days post symptoms onset and wear a mask around people for 10 days post symptom onset. Advised patient to monitor O2 levels at home.    COVID-19 - Symptom onset 12/21 with cough, sore throat, congestion, fever, and confusion when febrile. Positive test 12/24. Vaccinated and boosted. Received 4 total shots with last in April 2022.  - CXR on admit w/ few areas of interstitial changes but overall unremarkable. - Briefly on 1-2L. Received 1 dose dexamethasone.  - Does not qualify for remdesivir. Considered paxlovid on discharge however concern for significant interaction with eliquis.  - Weaned off O2 and no need for home O2. Follow up with PCP in 1 week.    Acute encephalopathy, resolved - In setting of parkinson's disease and likely metabolic with hyponatremia contributing. Reported periods of confusion when she was febrile PTA, would improve as fever resolved. - CT head on admission unremarkable. - Alert and oriented on exam this morning without focal neurological deficits.   Hyponatremia - Likely in setting of PO intake. Sodium 126 on admission. Was started on LR infusion for about ~1.5 L in. - Urine sodium of 46. Osmolality 275. - Improved to 130 s/p fluids.    Permanent Atrial Fibrillation - With single-chamber pacemaker.  Follows with Dr.  - Continue home Eliquis and Coreg.  Parkinson's disease - Follows with Dr. in movement clinic and on carbidopa/levodopa and midodrine for orthostasis. - Continue home dosing of carbidopa/levodopa. Patient has follow up scheduled with neurology.   Hypertension with history of orthostatic hypotension - Continue home carvedilol 12.5 mg daily and midodrine with carbidopa/levodopa orthostasis. - Can tolerate some supine hypertension if needed.   Hypothyroidism - Continue home Armour Thyroid 60 mg daily.   Depression and anxiety - Continue home paroxetine
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Urine osmolarity, Urine sodium normal
Clinical narrative: Patient is a 79 y.o. female admitted to the hospital on 12/25/2022 for with fever, intermittent confusion, cough, and positive COVID test. Symptoms improved with fluids and supportive therapy. Briefly placed on 2L O2 however likely did not need this. Received 1 dose of dexamethasone. Discharge home with no changes to meds. Considered paxlovid however avoided due to interaction with home eliquis.   Discharge Diagnosis and Hospital Course   Comments/Problems to be Addressed After Discharge - Follow up with PCP in 1 week for hospital follow up. Isolate for 5 days post symptoms onset and wear a mask around people for 10 days post symptom onset. Advised patient to monitor O2 levels at home.    COVID-19 - Symptom onset 12/21 with cough, sore throat, congestion, fever, and confusion when febrile. Positive test 12/24. Vaccinated and boosted. Received 4 total shots with last in April 2022.  - CXR on admit w/ few areas of interstitial changes but overall unremarkable. - Briefly on 1-2L. Received 1 dose dexamethasone.  - Does not qualify for remdesivir. Considered paxlovid on discharge however concern for significant interaction with eliquis.  - Weaned off O2 and no need for home O2. Follow up with PCP in 1 week.    Acute encephalopathy, resolved - In setting of parkinson's disease and likely metabolic with hyponatremia contributing. Reported periods of confusion when she was febrile PTA, would improve as fever resolved. - CT head on admission unremarkable. - Alert and oriented on exam this morning without focal neurological deficits.   Hyponatremia - Likely in setting of PO intake. Sodium 126 on admission. Was started on LR infusion for about ~1.5 L in. - Urine sodium of 46. Osmolality 275. - Improved to 130 s/p fluids.    Permanent Atrial Fibrillation - With single-chamber pacemaker.  Follows with Dr.  - Continue home Eliquis and Coreg.  Parkinson's disease - Follows with Dr. in movement clinic and on carbidopa/levodopa and midodrine for orthostasis. - Continue home dosing of carbidopa/levodopa. Patient has follow up scheduled with neurology.   Hypertension with history of orthostatic hypotension - Continue home carvedilol 12.5 mg daily and midodrine with carbidopa/levodopa orthostasis. - Can tolerate some supine hypertension if needed.   Hypothyroidism - Continue home Armour Thyroid 60 mg daily.   Depression and anxiety - Continue home paroxetine
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Blood test, Echocardiogram, Electrocardiogram, Pain in extremity
Clinical narrative: He got his vaccine and had no real adverse reactions other than minimal sore arm.  13 days later he started having A-fib, which he had with the 3rd vaccine, same exact circumstance as this was, 13 days after vaccine, 3:30 in the AM and then dissipated within 6 hours.  He went to the hospital.  He was treated with Metoprolol, full strength aspirin and had him hooked up to IV's with saline.  They didn't do anything else but let time pass until it went away.  He had a lot of tests, EKG, CAT scans blood work, Echocardiogram.  He was determined to be OK and sent home.   Even with this medication he had the same reaction with the 4th vaccine.    He called his doctor and was told that since he had this before there was no reason to go to the ER and to take the medication that he was already one since the 3rd vaccine.  He did want to speak with the doctor which he did not, but the episode did go away on it's own.  He spoke to the doctor yesterday and told him what had happened and said that maybe the vaccine was a trigger, but no definite.  It did seem coincidental that this has happened to him again after this vaccine.      The episode went away after 6 hours and did not come back until he took the 2nd booster and the same reaction, same time, same outcome as the first time.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Cardiac stress test, Computerised tomogram, Headache, Heart rate irregular
Clinical narrative: Severe flu like symptoms for 2 days initially.  I now have an erratic heartbeat and blood pressure with periodic AFib
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Influenza like illness, Myocardial necrosis marker, Nausea, Vomiting
Clinical narrative: Severe flu like symptoms for 2 days initially.  I now have an erratic heartbeat and blood pressure with periodic AFib
Age: 9.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Immunisation reaction, Incorrect dose administered
Clinical narrative: Pfizer bivalent 12 and up was administered to 9 year old in error. Dose administered was 0.2ml.  Parent notified, child had normal expected reaction following vaccine. 01/04/2023 child had mild headache. Also received influenza vaccine same day.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Herpes zoster reactivation, X-ray of pelvis and hip
Clinical narrative: Mild pain right hip comes and goes. After 2nd  booster reactivated shingles, arthritis pain getting worse. After 3rd booster shingles every month and arthritis pain in right hip has gotten bad.  Pfizer 3/4/2021, Pfizer 10/28/2021 Pharmacy, Pfizer 4/5/2022 Pharmacy, Pfizer 9/7/2022 Pharmacy
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Pain in extremity
Clinical narrative: I tested positive for COVID-19 on 12/4/22. I had a terrible sore throat, a low-grade fever, fatigue, and a slight cough. Also, I had severe pain in my feet. This lasted for about 5 days. I contacted my doctor and was prescribed 5 days worth of PAXLOVID. I couldn't tell if PAXLOVID helped or not. I am feeling much better now.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 on 12/4/22. I had a terrible sore throat, a low-grade fever, fatigue, and a slight cough. Also, I had severe pain in my feet. This lasted for about 5 days. I contacted my doctor and was prescribed 5 days worth of PAXLOVID. I couldn't tell if PAXLOVID helped or not. I am feeling much better now.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Chills, Fatigue, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: I contacted my doctor through the portal telling her I tested positive for COVID-19. She prescribed PAXLOVID. I started it that night. It was supposed to be five days of treatment, but I only took it for two and a half days. PAXLOVID made me feel worse. I couldn't eat or sleep. My symptoms were mild. I just felt tired. I also had a sore throat, congestion, and chills. The chills only lasted the first night. It took me two weeks before I tested negative for COVID-19 again.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I contacted my doctor through the portal telling her I tested positive for COVID-19. She prescribed PAXLOVID. I started it that night. It was supposed to be five days of treatment, but I only took it for two and a half days. PAXLOVID made me feel worse. I couldn't eat or sleep. My symptoms were mild. I just felt tired. I also had a sore throat, congestion, and chills. The chills only lasted the first night. It took me two weeks before I tested negative for COVID-19 again.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Amenorrhoea, Autoimmune thyroiditis, Colonoscopy normal, Fatigue
Clinical narrative: The day after the vaccine started feeling severe flu symptoms; Was worse than previous COVID-19 vaccine reactions; Took a COVID-19 test and it was negative; Reaction lasted for 2 weeks; Over the next couple of months started having heart palpitation's with extreme fatigue and weight gain, GI problems and stopped getting period; Went to doctor to rule out Pregnancy; Doctor ran blood testing and it was determined that Thyroid levels were off; Was sent to Endocrinologist and was diagnosed with Hashimoto's Syndrome; Was prescribed levothyroxine, propranolol and started taking magnesium; Was given a Colonoscopy because of new Gastro problems.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic enzyme abnormal, Influenza, Palpitations, SARS-CoV-2 test negative, Weight increased
Clinical narrative: The day after the vaccine started feeling severe flu symptoms; Was worse than previous COVID-19 vaccine reactions; Took a COVID-19 test and it was negative; Reaction lasted for 2 weeks; Over the next couple of months started having heart palpitation's with extreme fatigue and weight gain, GI problems and stopped getting period; Went to doctor to rule out Pregnancy; Doctor ran blood testing and it was determined that Thyroid levels were off; Was sent to Endocrinologist and was diagnosed with Hashimoto's Syndrome; Was prescribed levothyroxine, propranolol and started taking magnesium; Was given a Colonoscopy because of new Gastro problems.
Age: 5.0
Sex: F
Vaccine: DTPPVHBHPB
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was due for her Influenza vaccine at the appointment. Vaxelis was mistakenly administered instead at 11:45AM.  Mother was made aware of error at 11:48. Patient currently not experiencing any adverse reaction, and will return at a later date for her Influenza vaccine. Mother aware of potential reaction types and voiced understanding.
Age: 50.0
Sex: M
Vaccine: COVID19-2, FLUC4
Symptoms: Injection site scab, Injection site vesicles
Clinical narrative: He got his vaccines, he didn't notice it until a couple of days later when he was getting out of the shower that both injection sites were bubbly and scabbing.  The scab is still present on both of them as of today.  He did not put anything on the arm.  It's healing on it's own.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Positive COVID test on 11/30/2022
Age: 7.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, Fatigue, Injection site reaction, Malaise
Clinical narrative: Patient received an expired pfizer bivalent dose (Beyond used date: 12/27/2022; administered on 01/02/2023). Spoke to patient's mother and she said patient feels Injection site reactions, tired, and overall malaise.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Fatigue, Pain in extremity, Pyrexia, Tinnitus
Clinical narrative: At the time of the shots nothing unusual but sore arm, fever and fatigue.  AFTER having COVID-19 IN January 2022, I have had continuous non-stop tinnitus!!
Age: 52.0
Sex: U
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Feeling hot, Headache, Influenza virus test negative
Clinical narrative: 1/2/23 I woke up with a sore throat and a pounding headache. I took extra strength TYLENOL, and it would not go away. On 1/3/23, it all felt even worse, and I felt nauseous and hot like a fever. I went to the urgent care and had a fever of 102. I was tested for COVID which was positive and was prescribed PAXLOVID. I started taking it yesterday and today I am feeling a little better. I have a runny nose, coughing a lot, stuffy nose and get hot off and on and still have a fever.
Age: 52.0
Sex: U
Vaccine: COVID19-2
Symptoms: Nasal congestion, Nausea, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: 1/2/23 I woke up with a sore throat and a pounding headache. I took extra strength TYLENOL, and it would not go away. On 1/3/23, it all felt even worse, and I felt nauseous and hot like a fever. I went to the urgent care and had a fever of 102. I was tested for COVID which was positive and was prescribed PAXLOVID. I started taking it yesterday and today I am feeling a little better. I have a runny nose, coughing a lot, stuffy nose and get hot off and on and still have a fever.
Age: 52.0
Sex: U
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 1/2/23 I woke up with a sore throat and a pounding headache. I took extra strength TYLENOL, and it would not go away. On 1/3/23, it all felt even worse, and I felt nauseous and hot like a fever. I went to the urgent care and had a fever of 102. I was tested for COVID which was positive and was prescribed PAXLOVID. I started taking it yesterday and today I am feeling a little better. I have a runny nose, coughing a lot, stuffy nose and get hot off and on and still have a fever.
Age: 79.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Brain natriuretic peptide increased, COVID-19, Chest X-ray abnormal, Dyspnoea, Emphysema
Clinical narrative: COVID+ 12/31/2022.  Vaccination status - Moderna x2 + Pfizer x1 Discharge Physician: PRIVATE MD, MPH Primary Care Physician: PRIVATE, MD  Date of Admission: 12/31/2022 Discharge Date: 1/1/2023 Room Number: 2021/2021-1   BRIEF OVERVIEW:   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 01/01/2023 Yes ? Pulmonary emphysema (HCC) 01/01/2023 Yes ? Chronic systolic heart failure (HCC) 10/26/2022 Yes ? Amiodarone pulmonary toxicity 10/07/2022 Yes ? Hypertension   Yes ? Biventricular automatic implantable cardioverter defibrillator in situ 01/15/2014 Yes ? Cardiomyopathy (HCC)   DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 y.o. male who presents today with shortness of breath. He has a history of dilated cardiomyopathy with an EF of 29%, ICD, chronic systolic heart failure, HTN, CAD, and pulmonary toxicity from amiodarone.   In the ER the patient was initially 93% on room air, but oxygen desaturation to 87% occurred with ambulation with prolonged recovery.  He was placed on 2 Liters NC.  He tested positive for COVID.  Labs included BNP 3,540, procalcitonin 0.08, normal WBC of 8.49.  CXR showed emphysema.  Hospitalist service consulted for admission further evaluation.  He was initiated on dexamethasone and was outside window therapeutic benefit for Remdesivir.  He was quickly weaned to room air with stable oxygenation.  Patient was advised to follow-up outpatient pulmonology and obtain PFTs which are currently scheduled for 1/27 with local Medical Group pulmonology. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 79.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Hypoxia, Oxygen saturation decreased, Procalcitonin, Pulmonary toxicity, SARS-CoV-2 test positive
Clinical narrative: COVID+ 12/31/2022.  Vaccination status - Moderna x2 + Pfizer x1 Discharge Physician: PRIVATE MD, MPH Primary Care Physician: PRIVATE, MD  Date of Admission: 12/31/2022 Discharge Date: 1/1/2023 Room Number: 2021/2021-1   BRIEF OVERVIEW:   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 01/01/2023 Yes ? Pulmonary emphysema (HCC) 01/01/2023 Yes ? Chronic systolic heart failure (HCC) 10/26/2022 Yes ? Amiodarone pulmonary toxicity 10/07/2022 Yes ? Hypertension   Yes ? Biventricular automatic implantable cardioverter defibrillator in situ 01/15/2014 Yes ? Cardiomyopathy (HCC)   DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 y.o. male who presents today with shortness of breath. He has a history of dilated cardiomyopathy with an EF of 29%, ICD, chronic systolic heart failure, HTN, CAD, and pulmonary toxicity from amiodarone.   In the ER the patient was initially 93% on room air, but oxygen desaturation to 87% occurred with ambulation with prolonged recovery.  He was placed on 2 Liters NC.  He tested positive for COVID.  Labs included BNP 3,540, procalcitonin 0.08, normal WBC of 8.49.  CXR showed emphysema.  Hospitalist service consulted for admission further evaluation.  He was initiated on dexamethasone and was outside window therapeutic benefit for Remdesivir.  He was quickly weaned to room air with stable oxygenation.  Patient was advised to follow-up outpatient pulmonology and obtain PFTs which are currently scheduled for 1/27 with local Medical Group pulmonology. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 79.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: White blood cell count normal
Clinical narrative: COVID+ 12/31/2022.  Vaccination status - Moderna x2 + Pfizer x1 Discharge Physician: PRIVATE MD, MPH Primary Care Physician: PRIVATE, MD  Date of Admission: 12/31/2022 Discharge Date: 1/1/2023 Room Number: 2021/2021-1   BRIEF OVERVIEW:   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 01/01/2023 Yes ? Pulmonary emphysema (HCC) 01/01/2023 Yes ? Chronic systolic heart failure (HCC) 10/26/2022 Yes ? Amiodarone pulmonary toxicity 10/07/2022 Yes ? Hypertension   Yes ? Biventricular automatic implantable cardioverter defibrillator in situ 01/15/2014 Yes ? Cardiomyopathy (HCC)   DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 80 y.o. male who presents today with shortness of breath. He has a history of dilated cardiomyopathy with an EF of 29%, ICD, chronic systolic heart failure, HTN, CAD, and pulmonary toxicity from amiodarone.   In the ER the patient was initially 93% on room air, but oxygen desaturation to 87% occurred with ambulation with prolonged recovery.  He was placed on 2 Liters NC.  He tested positive for COVID.  Labs included BNP 3,540, procalcitonin 0.08, normal WBC of 8.49.  CXR showed emphysema.  Hospitalist service consulted for admission further evaluation.  He was initiated on dexamethasone and was outside window therapeutic benefit for Remdesivir.  He was quickly weaned to room air with stable oxygenation.  Patient was advised to follow-up outpatient pulmonology and obtain PFTs which are currently scheduled for 1/27 with local Medical Group pulmonology. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Angiogram abnormal, Asthenia, COVID-19, Cerebral infarction, Cerebrovascular accident
Clinical narrative: I had 2 episodes where I got really weak, and I went in to be seen in the ER. I advised them that I was weak and they did a CAT scan. I got a fever of 100.4 and I was admitted on November 18, 2022. They did a COVID-19 PCR, and it came back positive Sunday Morning I was given 3 days of remdesivir. I started Occupational and Physical therapy on November 19, 2022. I residual weakness. I remained in the hospital for 1 week and acute rehab for 1 week. I am still in physical rehab. I covered from the COVID-19 but not from the stroke.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had 2 episodes where I got really weak, and I went in to be seen in the ER. I advised them that I was weak and they did a CAT scan. I got a fever of 100.4 and I was admitted on November 18, 2022. They did a COVID-19 PCR, and it came back positive Sunday Morning I was given 3 days of remdesivir. I started Occupational and Physical therapy on November 19, 2022. I residual weakness. I remained in the hospital for 1 week and acute rehab for 1 week. I am still in physical rehab. I covered from the COVID-19 but not from the stroke.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Malaise, Mobility decreased, Oropharyngeal pain
Clinical narrative: On 12/24 was coughing and sore throat. No fever and general feeling of unwell. Took at home rapid home test and it was positive. Went to local ER and was prescribed PAXLOVID. 12/25 symptoms worsened and I spent all day in bed. 12/26 symptoms began improving after 3rd dose of PAXLOVID. 12/27 Symptoms completely resolved.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: On 12/24 was coughing and sore throat. No fever and general feeling of unwell. Took at home rapid home test and it was positive. Went to local ER and was prescribed PAXLOVID. 12/25 symptoms worsened and I spent all day in bed. 12/26 symptoms began improving after 3rd dose of PAXLOVID. 12/27 Symptoms completely resolved.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Headache
Clinical narrative: I had a very severe sore throat, achy headache, stuffy nose, and body aches and chills. For one day, I got sick on Sunday so I made an appointment for the next day to see if it was strep throat since my at-home COVID-19 test came back negative. However, the next day, I couldn't smell or taste anything so I took another test which came back positive. My physician initially prescribed me a steroid for the initial strep throat, but after determining it was COVID-19, she prescribed me PAXLOVID to aid my symptoms. Currently, I'm doing so much better and finally recovered.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Malaise, Nasal congestion, Oropharyngeal pain, Pain, SARS-CoV-2 test positive
Clinical narrative: I had a very severe sore throat, achy headache, stuffy nose, and body aches and chills. For one day, I got sick on Sunday so I made an appointment for the next day to see if it was strep throat since my at-home COVID-19 test came back negative. However, the next day, I couldn't smell or taste anything so I took another test which came back positive. My physician initially prescribed me a steroid for the initial strep throat, but after determining it was COVID-19, she prescribed me PAXLOVID to aid my symptoms. Currently, I'm doing so much better and finally recovered.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Hyporesponsive to stimuli, Hypoxia, Pyrexia
Clinical narrative: Patient was brought to the local ER for c/o fever, cough and decreased responsiveness per his wife.  Patient was found to have Covid during testing.  Patient was hypoxic on arrival and was admitted with a diagnosis of Covid-19 and dementia for further evaluation and treatment.  Patient was discharged home 1/3/23 with Home Health.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Bone pain, Dizziness, Fatigue
Clinical narrative: When I got the shot I started getting really fatigued. The following days my muscles, joints hurt, I was in bed for 3 days because it was very difficult to move. I had brain fog and stiff neck. From there I've yet to get back to 100%. It's like my whole body is in pain and I've gotten a lot of dizzy spells. Also weakness and bone pain. It really all started after this booster shot.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Malaise, Mobility decreased, Musculoskeletal stiffness, Myalgia
Clinical narrative: When I got the shot I started getting really fatigued. The following days my muscles, joints hurt, I was in bed for 3 days because it was very difficult to move. I had brain fog and stiff neck. From there I've yet to get back to 100%. It's like my whole body is in pain and I've gotten a lot of dizzy spells. Also weakness and bone pain. It really all started after this booster shot.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: When I got the shot I started getting really fatigued. The following days my muscles, joints hurt, I was in bed for 3 days because it was very difficult to move. I had brain fog and stiff neck. From there I've yet to get back to 100%. It's like my whole body is in pain and I've gotten a lot of dizzy spells. Also weakness and bone pain. It really all started after this booster shot.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Feeling abnormal, Headache
Clinical narrative: My COVID-19 symptoms started on 12/12/2022 in afternoon around 04:30PM. I had body aches, headaches, congestions, brain fog, and chills. On 12/13/2022 I had cough along with other symptoms. I also did a COVID-19 home test which was positive. On day 4 all the symptoms got worse. On 12/15/2022 I called my doctor's office and they prescribed me with PAXLOVID for 5 days.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: My COVID-19 symptoms started on 12/12/2022 in afternoon around 04:30PM. I had body aches, headaches, congestions, brain fog, and chills. On 12/13/2022 I had cough along with other symptoms. I also did a COVID-19 home test which was positive. On day 4 all the symptoms got worse. On 12/15/2022 I called my doctor's office and they prescribed me with PAXLOVID for 5 days.
Age: 11.0
Sex: M
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Bexsero given in error when Menveo was ordered
Age: 75.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Fatigue, Nasal congestion, Nasopharyngitis, Respiratory tract congestion
Clinical narrative: On Monday 11/14 I had a stuffy nose and thought I had caught a cold so took some ZICAM and AIRBORNE. on 11/15 I took two COVID-19 tests and they were both negative. We flew home on 11/16 and noticed I was getting more congested. I took a COVID-19 test when I got home and was absolutely positive. I called my doctor and we agreed that I did not need any antiviral, but that I just needed to rest and drink plenty of fluids. I was congested and extremely fatigued. I've never been so tired in my life, but 10 days later I tested negative.